Abstract CN14
Background
This study is part of the implementation of m-Health in outpatient Clinical Pharmacy at Hospital of the Principality of Andorra, with the aim of knowing the qualification of the Abeona Health App by the patient when using it for three months. The main objectives are: 1. Determine the general rating of the App according to the patient. 2 and 3. Know if the patient would continue using the App for one year and if they would recommend the App.
Methods
Cross-sectional study in onco-haematological patients under treatment with OAAs. 1. Inclusion criteria: all adult patients treated with OAAs seen from November 2022 to May 2023 (6 months of study). 2. Tool measure: the validated spanish translation of uMars survey was chosen to meet the research objectives. 3. Data collected from the patients: age, sex, type of tumour and type of OAAs. 4. Data collected from the surveys: the uMARS questions that were used to evaluate the Abeona Health App were: 2.4, 5, 6, 7, 8, 9, 10, 11, 12, 17, 18, and 20. 5. Statistical analysis: descriptive, performed with the Jamovi statistical package. 6. Ethical aspects: before providing the surveys, the patients were informed that their data would be treated anonymously, and they gave their signed informed consent to participate.
Results
64 patients were visited. 44 participated in the study (4 of them through their children for not knowing how to use an App). 41 were women (64%) and 23 men (36%) with a mean age of 63 years. The most frequent tumor in women was the breast with OAAs Palbocilic and in men the Colon with Capecitabine. The general quality of the App according to the patient's response in the uMars survey was: 7.7% of the patients scored 3, 50% scored 4 and 42.3% scored 5. When referring to the use of the App for a year, 19.2% of the patients responded from 3 to 10 times, 46.2% from 10 to 50 times, and 34.6% more than 50 times. In relation to whether patients would recommend the App, 30.8% of the patients answered that they would recommend it to many people and 69.2% that they would recommend it to everyone.
Conclusions
1. The Abeona Health App was rated with a score of more than 4 for 92.3% of patients. 2. The 80.8% of patients would continue using it for a year. 3. The 100% of patients would recommend it to people who could benefit from it.
Clinical trial identification
Editorial acknowledgement
Legal entity responsible for the study
The authors.
Funding
Has not received any funding.
Disclosure
All authors have declared no conflicts of interest.
Resources from the same session
CN23 - Understand the patients’ perspectives based on their profile to improve health-related quality of life assessment in breast cancer
Presenter: Cynthia Lesbros
Session: Poster session 25
Resources:
Abstract
CN31 - A qualitative study investigating the perception of simultaneous care in nurses
Presenter: Daniela Tregnago
Session: Poster session 25
Resources:
Abstract
CN32 - Exploring the content and outcomes of meaning-centered interventions in palliative care: A scoping review
Presenter: Yasemin Eskigülek
Session: Poster session 25
Resources:
Abstract
CN33 - Health care professionals’ perceptions regarding shared clinical decision-making in both acute and palliative cancer care, a qualitative study and its clinical implications
Presenter: Helena Ullgren
Session: Poster session 25
Resources:
Abstract
CN34 - Pallium game: The use of a card game in palliative care
Presenter: Bruno Magalhães
Session: Poster session 25
Resources:
Abstract
CN42 - A pharmacist-led interprofessional medication adherence program improved adherence to oral anticancer therapies: The OpTAT randomized controlled trial
Presenter: Carole Bandiera
Session: Poster session 25
Resources:
Abstract
CN43 - Development, implementation and evaluation of a cancer survivorship care program
Presenter: Flore Herman
Session: Poster session 25
Resources:
Abstract
CN45 - Exercise training following surgery and chemotherapy for ovarian cancer: A realist evaluation of a co-designed implementation process
Presenter: deirdre mc grath
Session: Poster session 25
Resources:
Abstract
CN46 - Experiences and sexuality of participants with a permanent colostomy after cancer treatment: A qualitative study
Presenter: kelly Van der Eecken
Session: Poster session 25
Resources:
Abstract
CN48 - Mobile response and prevention unit: Mobile information and management unit a collaboration between “Care In Adult Cancer Patients” nursing research laboratory and “Cancer Guidance Center” a non-profit organization (Kapa3)
Presenter: Evangeli Bista
Session: Poster session 25
Resources:
Abstract